Assays - Thiamine

High-Performance Liquid Chromatography Determination of Total Thiamine in Human Plasma

Author: H. J. Mascher, C. Kikuta
Publisher: Methods Enzymol. Vol. 279 (Eds. D.B. McCormick, Academic Press 1997)

Thiamine lends itself to clinical and therapeutic use in the prevention and treatment of vitamin B1 deficiencies. Thiamine (T) is present endogenously, mainly in the form of various phosphates, of which thiamin diphosphate (pyrophosphate) predominates in plasma. For relative bioavailability studies, determination of total T is performed after separation of the different T phosphates by phosphatase. The literature contains only a few studies on the detection of T in rat or human blood or human plasma, especially determination in connection with bioavailability studies.

High-Performance Liquid Chromatography Determination of Total Thiamine in human plasma for oral bioavailability studies

Author: H.J. Mascher, C. Kikuta
Publisher: J. Pharm. Sci., 82 (1993), 56-59

A high-performance liquid chromatographic method for the determination of total thiamine in plasma was developed for a relative bioavailability comparison of two oral thiamine preparations. After separation of thiamine mono- and diphosphates with the phosphatase enzyme, the total thiamine was subjected to reversed-phase high-peformance liquid chromatography, postcolumn oxidized to thiochrome with K3[Fe(CN)6], and detected by fluorescence. In the bioavailability study, 16 human subjects were put on a low-thiamine diet for 3 days. On the 2nd and 3rd days, 14 blood samples per subject and day were taken at the same times each day. Drug administration did not take place until the 3rd day. After deduction of the native concentrations of total thiamine detected on the 2nd day (mean value of ~ 7 ng/ml), the post-treatment pharmacokinetic parameters were determined (two different preparations, each with 200 mg of thiamine.HCl).